Remarkably, all classes of chemotherapeutic agents led to increased COX-2 transcription when used at concentrations that induced cancer cell growth arrest, indicating that activation of the COX-2/PGE2 pathway happens independently of the drug mechanism of action. This evidence concerns the gene PTGS2 and cancer.